FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Radnostix Sodium Iodide Recall

Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial

Radnostix · Idaho Falls, ID

Risk level
Class II
Reported by FDA
Mar 11, 2026
Recall ID
D-0389-2026
Check your lot numberHow we source this data

Summary

Radnostix recalled Sodium Iodide starting Jan 26, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0389-2026 on Mar 11, 2026. Reason: Presence of Particulate Matter: Due to production issues. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter: Due to production issues

Product description

Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.

Lot numbers, UPCs & expiration codes

Batch I012626R-01, Exp 02/09/2026

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0389-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jan 26, 2026
FDA report date
Mar 11, 2026
Quantity
16 units
Recall type
Voluntary: Firm initiated
Recalling firm
Radnostix

Original FDA data

Every field from FDA enforcement report D-0389-2026, exactly as published.

Show all FDA fields
City
Idaho Falls
State
ID
Status
Ongoing
Country
United States
Event ID
98470
Address
4137 Commerce Cir
Code information
Batch I012626R-01, Exp 02/09/2026
Postal code
83401-1205
Report date
Mar 11, 2026
Product type
Drugs
Recall number
D-0389-2026
Classification
Class II
Recalling firm
Radnostix
Product quantity
16 units
Reason for recall
Presence of Particulate Matter: Due to production issues
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Jan 26, 2026
Initial firm notification
Letter
Center classification date
Mar 13, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0389-2026, published Mar 11, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls